The role of the hyperactive MAPK3/1 (ERK1/2) pathway in cardiolaminopathy has been studied using pharmacological inhibition [74], which normalized the expression of the remodeling- and HF-associated natriuretic peptides A/B (NPPA/B). The gene discussed is NPPA; the disease is hydrops fetalis.